Galderma India introduces country's first proven regenerative biostimulator Sculptra

Swiss firm Galderma has announced the launch of Sculptra® in India, introducing the first proven regenerative biostimulator. Backed by more than 25 years of clinical evidence globally, Sculptra represents a new generation of injectable aesthetics that works with the body's natural collagen production to gradually restore facial volume, improve skin quality and deliver natural-looking, long-lasting results when administered by a qualified healthcare professional.

The launch marks an important milestone in India's rapidly evolving aesthetics landscape, where growing awareness around skin health, minimally invasive options and personalised solutions are redefining consumer expectations. 

Raghavendra Sadashiva, Managing Director, Galderma India & South Asia said, "The introduction of Sculptra marks an exciting milestone for India's aesthetics landscape as regenerative dermatology continues to gain momentum globally In addition to addressing the visible signs of ageing, Sculptra works with the body's natural collagen production to support gradual, natural-looking improvements in skin quality and facial structure."

In addition to restoring volume Sculptra also helps address collagen loss associated with the natural ageing process. As collagen production naturally decreases over time, the skin begins to lose its structural support, resulting in reduced firmness, volume loss and the appearance of wrinkles. Through its unique PLLA-SCA™ formulation, Sculptra stimulates the body's own collagen production, helping gradually restore the skin's underlying structure while maintaining natural facial expressions and individuality.

The introduction of Sculptra further strengthens Galderma India's Injectable Aesthetics portfolio and reflects the company's continued commitment to bringing globally recognised innovations to Indian healthcare professionals.